
Opinion|Videos|March 28, 2024
Insights into Digital Therapeutics Space and Associated Evidence Thresholds
Diana Brixner, PhD, FAMCP, of the University of Utah opens a discussion surrounding digital therapeutics.
Advertisement
Episodes in this series

Now Playing
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial
3
A conversation about vaccines and monoclonal antibodies with Marc Elia, Chairman of Invivyd’s Board of Directors
4
New study confirms benefits of GLP-1 drugs in patients with PAD
5





























